GENE ONLINE|News &
PreveCeutical Medical Inc. Shifts to Semi-Annual Financial Reporting Schedule
PreveCeutical Medical Inc., a health sciences company, has announced a shift in its financial reporting practices. The company will now adopt a semi-annual financial reporting schedule, moving away from its previous quarterly reporting framework. This change is set to take effect immediately.
According to the announcement, the decision aligns with PreveCeutical’s efforts to streamline operations and focus resources on its ongoing research and development initiatives. By transitioning to semi-annual reporting, the company aims to provide shareholders with comprehensive updates while reducing administrative demands associated with more frequent filings. The new schedule will result in two financial reports per fiscal year, covering six-month periods each. Further details regarding this adjustment or any potential impacts on stakeholders were not disclosed in the statement.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 1, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Haloperidol Identified as Potential Treatment to Improve Muscle Function and Neuroprotection in Spinal Muscular Atrophy
2026-04-13
Advanced CRISPR System Using Al3Cas12f Enzyme Achieves 90 Percent Gene Editing Efficiency in Human Cells
2026-04-13
Researchers Map Pain-Sensing Neurons to Identify Proteins Linked to Chronic Inflammatory Pain
2026-04-13
FDA Grants Full Approval to Travere Therapeutics’ FILSPARI as First Medication for Treating FSGS
2026-04-13
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
